Filter Results:
(1,725)
Show Results For
- All HBS Web
(1,725)
- News (438)
- Research (1,075)
- Events (3)
- Multimedia (54)
- Faculty Publications (734)
Show Results For
- All HBS Web
(1,725)
- News (438)
- Research (1,075)
- Events (3)
- Multimedia (54)
- Faculty Publications (734)
- October 2015 (Revised September 2016)
- Technical Note
Flight: Now without Humans Aboard
By: Mitchell Weiss, Karim Lakhani, HT Kung and Kerry Herman
This note provides an overview of the unmanned aerial vehicles (UAVs, or drones) industry in September 2015. UAVs offered many potential applications in industries as diverse as aerial imaging and photography, agriculture, construction, infrastructure inspection and... View Details
- December 2017 (Revised January 2024)
- Case
Globalization Past, 1850–1914 (A)
By: Sophus A. Reinert and Federica Gabrieli
On the evening of 3 August 1914, British Foreign Secretary Lord Edward Grey contemplated whether to advise King and Parliament to declare war on Germany in the wake of the country’s invasion of Belgium or to stay out of what quickly was becoming a world war triggered... View Details
Keywords: The World; The Rise And Fall Of Globalization; World War; Globalization; War; Economics; Trade; Business Cycles; Economic Growth; Economic Slowdown and Stagnation; Society; History; Values and Beliefs; Macroeconomics
Reinert, Sophus A., and Federica Gabrieli. "Globalization Past, 1850–1914 (A)." Harvard Business School Case 718-023, December 2017. (Revised January 2024.)
- February 2014
- Teaching Note
Mylan Lab's Proposed Merger with King Pharmaceuticals
By: Lucy White
Perry Capital owns shares in King and, to facilitate approval of the merger, buys shares in Mylan, whilst hedging out its economic exposure to Mylan's share price using derivatives. The price at which Mylan proposes to merge with King is generous to King shareholders,... View Details
- November 2013
- Case
GlaxoSmithKline in China (A)
By: John A. Quelch and Margaret L. Rodriguez
Four GlaxoSmithKline employees were accused of bribing Chinese health care workers to prescribe the company's drugs. The accusations brought to light the questionable incentive structures of the Chinese health care system and the pressure on companies to adhere to... View Details
Keywords: Public Health; Pharmaceuticals; China; Bribery; CSR; Hong Bao; Health Care; Drug; GlaxoSmithKline; GSK; Witty; Government; Marketing; Health; Health Care and Treatment; Corporate Social Responsibility and Impact; Corporate Strategy; Corporate Governance; Business and Government Relations; Ethics; Pharmaceutical Industry; China; United Kingdom; United States
Quelch, John A., and Margaret L. Rodriguez. "GlaxoSmithKline in China (A)." Harvard Business School Case 514-049, November 2013.
- January 2009 (Revised February 2014)
- Case
Mylan Lab's Proposed Merger with King Pharmaceutical (Abridged)
By: Lucy White
Perry Capital owns shares in King and, to facilitate approval of the merger, buys shares in Mylan, whilst hedging out its economic exposure to Mylan's share price using derivatives. The price at which Mylan proposes to merge with King is generous to King shareholders,... View Details
Keywords: Mergers and Acquisitions; Voting; Ethics; Stock Shares; Investment; Lawsuits and Litigation; Ownership Stake
White, Lucy. "Mylan Lab's Proposed Merger with King Pharmaceutical (Abridged)." Harvard Business School Case 209-097, January 2009. (Revised February 2014.)
- 18 Feb 2009
- First Look
First Look: February 18, 2009
Business School Case 609-070 An abstract is not available at this time. Purchase this case: http://harvardbusinessonline.hbsp.harvard.edu /b01/en/common/item_detail.jhtml?id=609070 Alliance for a Green Revolution in Africa (AGRA) Harvard... View Details
Keywords: Martha Lagace
- January 2024
- Supplement
Frank Cornelissen: The Great Sulfite Debate (B)
By: Tiona Zuzul and Susan Pinckney
In 2018, artisanal Italian vineyard Frank Cornelissen was one of the world’s leading natural wine vineyards. Its founder, Frank Cornelissen, faced weather related conditions that forced him to have to decide between staying true to the tenets of the natural wine... View Details
Keywords: Budgets and Budgeting; Business Earnings; Plant-Based Agribusiness; Business Startups; Family Business; For-Profit Firms; Small Business; Change Management; Transition; Communication; Cost vs Benefits; Decisions; Entrepreneurship; Environmental Sustainability; Values and Beliefs; Financial Management; Financial Strategy; Profit; Revenue; Spending; Global Strategy; Goods and Commodities; Innovation Strategy; Crisis Management; Goals and Objectives; Growth Management; Success; Strategic Planning; Problems and Challenges; Risk and Uncertainty; Cognition and Thinking; Reputation; Adoption; Expansion; Weather; Mission and Purpose; Food and Beverage Industry; Agriculture and Agribusiness Industry; Europe; Italy
Zuzul, Tiona, and Susan Pinckney. "Frank Cornelissen: The Great Sulfite Debate (B)." Harvard Business School Supplement 724-398, January 2024.
- 01 Jun 2016
- News
Alumni and Faculty Books for June 2016
Alumni Books The Founder’s Mentality: How to Overcome the Predictable Crises of Growth by James Allen (MBA 1989) and Chris Zook (Harvard Business Review Press) Based on their decade-long study of companies in more than 40 countries, the... View Details
- 01 Dec 2018
- News
Hard Choices
their aspiration. Over dinner, Seth spoke passionately to the group about capitalism and the responsibilities of business leaders. His words resonated with many and I am delighted to share them here, for all the School’s alumni, with his... View Details
Keywords: Seth Klarman (MBA 1982)
- October 2023 (Revised April 2024)
- Case
Accounting Red Flags or Red Herrings at Catalent? (A)
By: Joseph Pacelli, ZeSean Ali and Tom Quinn
Fund manager Janet Curie asked for a recommendation about the pharmaceutical company Catalent. The company seemed like a solid investment. However, a pair of research reports issued over the previous two months complicated this narrative. GlassHouse Research, a short... View Details
Keywords: Accounting Audits; Budgets and Budgeting; Earnings Management; Cost Accounting; Fair Value Accounting; Revenue Recognition; Integrated Corporate Reporting; Fairness; Moral Sensibility; Values and Beliefs; Government Legislation; Conflict of Interests; Announcements; Blogs; Debates; Investment; Trust; Business and Shareholder Relations; Pharmaceutical Industry; Accounting Industry; United States
Pacelli, Joseph, ZeSean Ali, and Tom Quinn. "Accounting Red Flags or Red Herrings at Catalent? (A)." Harvard Business School Case 124-024, October 2023. (Revised April 2024.)
- 01 Jan 2012
- News
Franklin P. “Pitch” Johnson Jr., MBA 1952
also as an insightful manager, a man of high ethical standards, and a team player. He provides more than money—quite often, his advice and counsel have been the key elements that helped entrepreneurs transform a good idea into a great... View Details
- 15 Dec 2020
- Blog Post
MBA Voices Blog: A Year in Review
alumni have navigated this past year and provide important insights about the strength of our community. Here is our roundup of notable posts published in 2020: Harvard Business School Class of 2021 Student Profiles The Class of 2021 is... View Details
- August 2012
- Article
Consumer Response to Versioning: How Brands' Production Methods Affect Perceptions of Unfairness
By: Andrew Gershoff, Ran Kivetz and Anat Keinan
Marketers often extend product lines by offering limited-capability models that are created by removing or degrading features in existing models. This production method, called versioning, has been lauded because of its ability to increase both consumer and firm... View Details
Keywords: Brands and Branding; Production; Competency and Skills; Welfare or Wellbeing; Cost vs Benefits; Perception; Customers; Performance Evaluation; Fairness; Business Ventures
Gershoff, Andrew, Ran Kivetz, and Anat Keinan. "Consumer Response to Versioning: How Brands' Production Methods Affect Perceptions of Unfairness." Journal of Consumer Research 39, no. 2 (August 2012): 382–398. (Selected in 2017 for JCR Research Curations on “Behavioral Pricing”.)
- November 2008 (Revised October 2009)
- Case
American Cancer Society: Access to Care
By: Robert L. Simons and Kathryn Rosenberg
CEO John Seffrin decides to radically change the strategy of the American Cancer Society. The new Access to Care strategy relies on advocacy to change public policy and increase the number of Americans eligible for cancer prevention and treatment. The new strategy... View Details
Keywords: Values and Beliefs; Governance Controls; Leading Change; Organizational Change and Adaptation; Organizational Structure; Nonprofit Organizations; Business Strategy; Health Industry; United States
Simons, Robert L., and Kathryn Rosenberg. "American Cancer Society: Access to Care." Harvard Business School Case 109-015, November 2008. (Revised October 2009.)
- Web
Global Activities 2020-2021 - Global Activities 2021
Global Activities 2021 REPORT In a year shaped by the pandemic, Harvard Business School’s global presence has enabled the School to be at the forefront of the study of emerging trends. Faculty members draw on the resources and expertise... View Details
- December 2024 (Revised January 2025)
- Case
Balancing Returns and Responsibilities at Raya Partners
By: Arthur Segel, Ephraim Mernick, Derek C. M. van Bever and Olivia Barba
Raya Partners, a private equity firm, faces a crucial decision regarding Asa Specialty Coatings Company (ASCC). The dilemma involves shifting ASCC's manufacturing operations to Mexico, a move that would boost profitability and reduce emissions but result in significant... View Details
Keywords: Factories, Labs, and Plants; Communication Strategy; Private Equity; Job Cuts and Outsourcing; Corporate Social Responsibility and Impact; Environmental Sustainability; Values and Beliefs; Financial Services Industry; Manufacturing Industry; Mexico; Vermont
Segel, Arthur, Ephraim Mernick, Derek C. M. van Bever, and Olivia Barba. "Balancing Returns and Responsibilities at Raya Partners." Harvard Business School Case 325-068, December 2024. (Revised January 2025.)
- September 2002 (Revised August 2003)
- Case
Genzyme's Gaucher Initiative: Global Risk and Responsibility
By: Christopher A. Bartlett and Andrew N. McLean
In Egypt, Genzyme's humanitarian commitment to treat all sufferers of the rare Gaucher disease worldwide first confronts its commercial imperative to recoup the huge investment required to bring the drug Cerezyme to market. Here Tomye Tierney must decide how to balance... View Details
Keywords: Moral Sensibility; Investment; Emerging Markets; Negotiation; Corporate Social Responsibility and Impact; Business and Government Relations; Sales; Commercialization; Expansion; Value Creation
Bartlett, Christopher A., and Andrew N. McLean. "Genzyme's Gaucher Initiative: Global Risk and Responsibility." Harvard Business School Case 303-048, September 2002. (Revised August 2003.)
- November 1995 (Revised March 2004)
- Case
Massachusetts General Hospital: CABG Surgery (A)
By: Steven C. Wheelwright and James Weber
A cross-functional team at Massachusetts General Hospital tries to reengineer the service delivery process (the "care path") for heart bypass surgery (CABG) in order to shorten hospital stays (and lower costs) while maintaining/enhancing the quality of care provided. View Details
Keywords: Health Care and Treatment; Medical Specialties; Business Processes; Mission and Purpose; Product Positioning; Product Marketing; Management Practices and Processes; Customer Satisfaction; Service Delivery; Service Operations; Fair Value Accounting; Ethics; Pharmaceutical Industry; Health Industry; Massachusetts
Wheelwright, Steven C., and James Weber. "Massachusetts General Hospital: CABG Surgery (A)." Harvard Business School Case 696-015, November 1995. (Revised March 2004.)
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
Curriculum. "The private sector is increasingly welcome in fields that were long considered the provenance of government and social service organizations, and that is exciting news for the next generation of business leaders." Gilmartin... View Details
- June 2007 (Revised July 2008)
- Case
Kinder Morgan, Inc. - Management Buyout
Kinder Morgan, Inc., was a leader in the transportation and distribution of energy throughout North America, managing a master limited partnership with over $35 billion in infrastructure assets. In the summer of 2006, Richard Kinder, the founder and chairman of Kinder... View Details
Keywords: Leveraged Buyouts; Fairness; Governing and Advisory Boards; Privatization; Partners and Partnerships; Conflict of Interests; North America
El-Hage, Nabil N., Leslie Pierson, Ewa Bierbrauer, and Francine Chew. "Kinder Morgan, Inc. - Management Buyout." Harvard Business School Case 207-123, June 2007. (Revised July 2008.)